Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.
Circulation., Jul;126(1):76-82 (2012)
Dysregulation of the microvasculature in nonlesional non-sun-exposed skin of patients with lupus nephritis.
J. Rheumatol., Mar;39(3):510-5 (2012)
Preferential transmission of genetic risk variants of candidate loci at 6p21 from asymptomatic grandparents to mothers of children with neonatal lupus.
Arthritis Rheum., Mar;64(3):931-9 (2012)
Use of pharmacogenetics, enzymatic phenotyping, and metabolite monitoring to guide treatment with azathioprine in patients with systemic lupus erythematosus.
J. Rheumatol., Jan;36(1):89-95 (2009)
Antibody reactivity to alpha-enolase in mothers of children with congenital heart block.
J. Rheumatol., Mar;36(3):565-9 (2009)
Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk.
J. Intern. Med., Jun;265(6):653-62 (2009)
Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.
Arthritis Rheum., Oct;60(10):3091-7 (2009)
Updates on lupus and pregnancy.
Bull NYU Hosp Jt Dis., 67(3):271-5 (2009)
Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus.
Lupus., Mar;19(3):300-6 (2010)
Ro60-associated single-stranded RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block.
J. Immunol., Feb;184(4):2148-55 (2010)
Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.
Arthritis Rheum., Apr;62(4):1153-7 (2010)
Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine.
Ann. Rheum. Dis., Oct;69(10):1827-30 (2010)
Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block.
Circ. Res., Aug;107(3):374-87 (2010)
Identification of candidate loci at 6p21 and 21q22 in a genome-wide association study of cardiac manifestations of neonatal lupus.
Arthritis Rheum., Nov;62(11):3415-24 (2010)
Î²2-glycoprotein I and protection from anti-SSA/Ro60-associated cardiac manifestations of neonatal lupus.
J. Immunol., Jul;187(1):520-6 (2011)
A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congenital heart block.
J. Biol. Chem., Sep;286(35):30444-54 (2011)
Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.
Circulation., Nov;124(18):1927-35 (2011)
Binding of anti-SSA antibodies to apoptotic fetal cardiocytes stimulates urokinase plasminogen activator (uPA)/uPA receptor-dependent activation of TGF-Î² and potentiates fibrosis.
J. Immunol., Nov;187(10):5392-401 (2011)
Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block.
J. Clin. Invest., Sep;116(9):2413-22 (2006)
The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial.
Arthritis Rheum., Nov;54(11):3623-32 (2006)